Literature DB >> 4031340

Physicians' knowledge of prescribing for the elderly. A study of primary care physicians in Pennsylvania.

M E Ferry, P P Lamy, L A Becker.   

Abstract

The 143 physicians who returned to Temple University Medical School a questionnaire on knowledge of prescribing for the elderly constituted 25% of a stratified random sample of general practitioners (GPs), family practitioners (FPs), and practitioners in internal medicine (IMs) reimbursed under Medicare in Pennsylvania in 1979. The mean score on the 23-item drug questionnaire was significantly lower (P less than .05) than the score deemed adequate by a panel of six experts in the field. Five variables, identified by survey questions, were positively associated with physicians' test scores: importance of professional meetings, perception of need for continuing medical education, board eligibility/certification, group practice, and a practice in which the elderly constitute 25 to 49% of all patients. Two variables were negatively associated: number of years since date of licensure and the importance of drug advertisements. Respondents and nonrespondents were compared on nine variables for which American Medical Association (AMA), American Osteopathic Association (AOA), or Blue Shield data were available. Pennsylvania graduates were significantly overrepresented in the respondent group. The only other significant difference found was in field of practice, where findings differed by source of information. There was no significant difference in mean scores of early and late respondents. The research findings support those of three previous studies, not limited to the elderly, which found prescribing knowledge inadequate. They suggest the need for examining/improving the opportunities for medical students and physicians to increase their knowledge of geriatric pharmacology.

Entities:  

Mesh:

Year:  1985        PMID: 4031340     DOI: 10.1111/j.1532-5415.1985.tb06318.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  10 in total

1.  Prescribing drugs for the elderly: reaching therapeutic goals.

Authors:  H G Preiksaitis; M Gordon
Journal:  Can Fam Physician       Date:  1986-12       Impact factor: 3.275

2.  A sample argument.

Authors:  J Lexchin
Journal:  CMAJ       Date:  1991-01-15       Impact factor: 8.262

3.  The association between a journal's source of revenue and the drug recommendations made in the articles it publishes.

Authors:  Annette Becker; Fatma Dörter; Kirsten Eckhardt; Annika Viniol; Erika Baum; Michael M Kochen; Joel Lexchin; Karl Wegscheider; Norbert Donner-Banzhoff
Journal:  CMAJ       Date:  2011-02-28       Impact factor: 8.262

4.  Consequences of direct-to-consumer advertising of prescription drugs.

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1997-04       Impact factor: 3.275

5.  Why are we still poisoning the elderly so often?

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1993-11       Impact factor: 3.275

6.  Physicians and drug companies interact.

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1993-09       Impact factor: 3.275

7.  Relation between physician characteristics and prescribing for elderly people in New Brunswick.

Authors:  W Davidson; D W Molloy; G Somers; M Bédard
Journal:  CMAJ       Date:  1994-03-15       Impact factor: 8.262

8.  Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland.

Authors:  Macarena Gonzalez Santiago; Heiner C Bucher; Alain J Nordmann
Journal:  BMC Med Inform Decis Mak       Date:  2008-12-31       Impact factor: 2.796

Review 9.  Quality of pharmaceutical advertisements in medical journals: a systematic review.

Authors:  Noordin Othman; Agnes Vitry; Elizabeth E Roughead
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

10.  Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study.

Authors:  Brett D Montgomery; Peter R Mansfield; Geoffrey K Spurling; Alison M Ward
Journal:  BMC Public Health       Date:  2008-05-20       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.